Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-002567
Filing Date
2014-04-21
Accepted
2014-04-21 17:22:29
Documents
9
Period of Report
2014-02-28

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0214_il2minternational.htm 10-Q 597246
2 CERTIFICATION f10q0214ex31i_il2m.htm EX-31.1 16021
3 CERTIFICATION f10q0214ex32i_il2m.htm EX-32.1 6710
  Complete submission text file 0001213900-14-002567.txt   3431827

Data Files

Seq Description Document Type Size
4 XBRL dynh-20140228.xml EX-101.INS 368739
5 XBRL dynh-20140228.xsd EX-101.SCH 30893
6 XBRL dynh-20140228_cal.xml EX-101.CAL 32840
7 XBRL dynh-20140228_def.xml EX-101.DEF 80035
8 XBRL dynh-20140228_lab.xml EX-101.LAB 260029
9 XBRL dynh-20140228_pre.xml EX-101.PRE 193913
Mailing Address 3500 WEST OLIVE AVENUE SUITE 810 BURBANK CA 91505
Business Address 3500 WEST OLIVE AVENUE SUITE 810 BURBANK CA 91505 818-953-7585
il2m INTERNATIONAL CORP. (Filer) CIK: 0001520512 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-176587 | Film No.: 14774539
SIC: 2834 Pharmaceutical Preparations